Working… Menu

National Pregnancy Registry for Atypical Antipsychotics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01246765
Recruitment Status : Recruiting
First Posted : November 23, 2010
Last Update Posted : March 16, 2020
Alkermes, Inc.
Otsuka America Pharmaceutical
Teva Pharmaceutical Industries, Ltd.
Sage Therapeutics
Information provided by (Responsible Party):
Lee S. Cohen, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2023
Publications automatically indexed to this study by Identifier (NCT Number):